(Q54433454)
Statements
Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. (English)
1 reference
Rosenberg SA
1 reference
Mulé JJ
1 reference
Ettinghausen SE
1 reference
Spiess PJ
1 reference
Shu S
1 reference
1 February 1986
1 reference
1 reference
46
1 reference
2
1 reference
676-683
1 reference
Identifiers
1 reference